Pharmacotherapy of Opioids: Present and Future Developments

Overview

Journal Pharm World Sci

Publisher Springer

Specialties Pharmacology
Pharmacy

Date 1996 Jan 1

PMID 8861825

Citations 3

Authors

T F Meert

Affiliations

Soon will be listed here.

Abstract

The clinically available opioids have different physicochemical properties, resulting in differences in clinical profile with regard to potency, onset, and duration of activity. However, they all have comparable side-effects after acute systemic application. Several approaches can be used to overcome these side-effects. The following approaches, with special emphasis on the perioperative use of the opioids, are discussed: (1) the use of alternative routes of administration, such as via the spine (epidurally and intrathecally); (2) optimization of opioid delivery by means of slow-release preparations, chronic infusions with indwelling catheters, and transdermal delivery systems; (3) use of additional agents to potentiate the analgesic properties of the opioids so that the dose of opioid can be reduced; and (4) searching for new analgesics on the basis of knowledge of the pain-transmission system and the different opioid receptors with their functional interactions.

Citing Articles

The Oxford Catalogue of Opioids: A systematic synthesis of opioid drug names and their pharmacology.

Richards G, Sitkowski K, Heneghan C, Aronson J Br J Clin Pharmacol. 2021; 87(10):3790-3812.

PMID: 33608948 PMC: 8518704. DOI: 10.1111/bcp.14786.

Comparison of two automated solid phase extractions for the detection of ten fentanyl analogs and metabolites in human urine using liquid chromatography tandem mass spectrometry.

Shaner R, Kaplan P, Hamelin E, Bragg W, Johnson R J Chromatogr B Analyt Technol Biomed Life Sci. 2014; 962:52-58.

PMID: 24893271 PMC: 4812561. DOI: 10.1016/j.jchromb.2014.05.025.

Synthesis and investigations of double-pharmacophore ligands for treatment of chronic and neuropathic pain.

Vardanyan R, Vijay G, Nichol G, Liu L, Kumarasinghe I, Davis P Bioorg Med Chem. 2009; 17(14):5044-53.

PMID: 19540763 PMC: 2759397. DOI: 10.1016/j.bmc.2009.05.065.

References

Koren G, Sandler A, Klein J, Whiting W, Lau L, Slavchenko P . Relationship between the pharmacokinetics and the analgesic and respiratory pharmacodynamics of epidural sufentanil. Clin Pharmacol Ther. 1989; 46(4):458-62. DOI: 10.1038/clpt.1989.165. View

Grass J . Sufentanil: clinical use as postoperative analgesic--epidural/intrathecal route. J Pain Symptom Manage. 1992; 7(5):271-86. DOI: 10.1016/0885-3924(92)90061-l. View

Vercauteren M, Lauwers E, Meert T, De Hert S, Adriaensen H . Comparison of epidural sufentanil plus clonidine with sufentanil alone for postoperative pain relief. Anaesthesia. 1990; 45(7):531-4. DOI: 10.1111/j.1365-2044.1990.tb14824.x. View

Rothman R, Bykov V, JACOBSON A, Rice K, Long J, Bowen W . A study of the effect of the irreversible delta receptor antagonist [D-Ala2,Leu5,Cys6]-enkephalin on delta cx and delta ncx opioid binding sites in vitro and in vivo. Peptides. 1992; 13(4):691-4. DOI: 10.1016/0196-9781(92)90174-2. View

Ling G, Paul D, Simantov R, Pasternak G . Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion model. Life Sci. 1989; 45(18):1627-36. DOI: 10.1016/0024-3205(89)90272-5. View

Ranade V . Drug delivery systems. 6. Transdermal drug delivery. J Clin Pharmacol. 1991; 31(5):401-18. DOI: 10.1002/j.1552-4604.1991.tb01895.x. View

Thorat S, Veeranna , Reddy P, Bhargava H . Biochemical and behavioral studies on the interaction between mu- and kappa-opiate agonists in mice. Brain Res. 1993; 615(2):191-8. DOI: 10.1016/0006-8993(93)90029-m. View

Leicht C, Kelleher A, Robinson D, Dickerson S . Prolongation of postoperative epidural sufentanil analgesia with epinephrine. Anesth Analg. 1990; 70(3):323-5. DOI: 10.1213/00000539-199003000-00016. View

Mourisse J, Hasenbos M, Gielen M, Moll J, Cromheecke G . Epidural bupivacaine, sufentanil or the combination for post-thoracotomy pain. Acta Anaesthesiol Scand. 1992; 36(1):70-4. DOI: 10.1111/j.1399-6576.1992.tb03425.x. View

10.

Phillips G . Epidural sufentanil/bupivacaine combinations for analgesia during labor: effect of varying sufentanil doses. Anesthesiology. 1987; 67(5):835-8. DOI: 10.1097/00000542-198711000-00043. View

11.

Geller E, Chrubasik J, Graf R, Chrubasik S, Schulte-Monting J . A randomized double-blind comparison of epidural sufentanil versus intravenous sufentanil or epidural fentanyl analgesia after major abdominal surgery. Anesth Analg. 1993; 76(6):1243-50. DOI: 10.1213/00000539-199306000-00011. View

12.

Phillips G . Continuous infusion epidural analgesia in labor: the effect of adding sufentanil to 0.125% bupivacaine. Anesth Analg. 1988; 67(5):462-5. View

13.

Courtney M, Bader A, Hartwell B, Hauch M, Grennan M, Datta S . Perioperative analgesia with subarachnoid sufentanil administration. Reg Anesth. 1992; 17(5):274-8. View

14.

Vertommen J, Vandermeulen E, Van Aken H, Vaes L, Soetens M, van Steenberge A . The effects of the addition of sufentanil to 0.125% bupivacaine on the quality of analgesia during labor and on the incidence of instrumental deliveries. Anesthesiology. 1991; 74(5):809-14. DOI: 10.1097/00000542-199105000-00002. View

15.

Singh S, Singh J . Transdermal drug delivery by passive diffusion and iontophoresis: a review. Med Res Rev. 1993; 13(5):569-621. DOI: 10.1002/med.2610130504. View

16.

White P . Clinical uses of intravenous anesthetic and analgesic infusions. Anesth Analg. 1989; 68(2):161-71. DOI: 10.1213/00000539-198902000-00017. View

17.

TAKEMORI A, Portoghese P . Enkephalin antinociception in mice is mediated by delta 1- and delta 2-opioid receptors in the brain and spinal cord, respectively. Eur J Pharmacol. 1993; 242(2):145-50. DOI: 10.1016/0014-2999(93)90074-r. View

18.

Bach V, Carl P, Ravlo O, Crawford M, Werner M . Potentiation of epidural opioids with epidural droperidol. A one year retrospective study. Anaesthesia. 1986; 41(11):1116-9. DOI: 10.1111/j.1365-2044.1986.tb12959.x. View

19.

Glass P, Hardman D, Kamiyama Y, Quill T, Marton G, Donn K . Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg. 1993; 77(5):1031-40. DOI: 10.1213/00000539-199311000-00028. View

20.

Hasenbos M, Gielen M, Bos J, Tielbeek E, van Egmond J . High thoracic epidural sufentanil for post-thoracotomy pain: influence of epinephrine as an adjuvant--a double blind study. Anesthesiology. 1988; 69(6):1017-22. DOI: 10.1097/00000542-198812000-00046. View